Coronary artery disease is under-diagnosed and under-treated in advanced lung disease

American Journal of Medicine

Volumn 125, Issue 12, 2012, Pages

  Reed, Robert M ^a   Eberlein, Michael ^b   Girgis, Reda E ^c   Hashmi, Salman ^a   Iacono, Aldo ^a   Jones, Steven ^c   Netzer, Giora ^a   Scharf, Steven ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; Coronary artery disease; Interstitial lung disease; Lung transplantation; Pulmonary fibrosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC ERROR; DISEASE SEVERITY; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEART CATHETERIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG TRANSFER FACTOR; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; RACE; RESIDUAL VOLUME; RETROSPECTIVE STUDY; SMOKING; TOTAL LUNG CAPACITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84869223001     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.05.018     Document Type: Article

References (43)

1. J. Finkelstein, E. Cha, S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int J Chron Obstruct Pulmon Dis 4 2009 337 349
2. A.B. Newman, B.L. Naydeck, K. Sutton-Tyrrell, A. Feldman, D. Edmundowicz, L.H. Kuller Coronary artery calcification in older adults to age 99: prevalence and risk factors Circulation 104 2001 2679 2684
3. S.D. Nathan, A. Basavaraj, C. Reichner Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis Respir Med 104 2010 1035 1041
4. L. Huiart, P. Ernst, S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646
5. D.D. Sin, S.F. Man Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease Curr Opin Pulm Med 14 2008 115 121
6. A.L. Hansell, J.A. Walk, J.B. Soriano What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis Eur Respir J 22 2003 809 814
7. D.M. Mannino, R.A. Etzel, R.G. Parrish Pulmonary fibrosis deaths in the United States, 1979-1991 An analysis of multiple-cause mortality data Am J Respir Crit Care Med 153 1996 1548 1552
8. R.J. Panos, R.L. Mortenson, S.A. Niccoli, T.E. King Jr Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment Am J Med 88 1990 396 404
9. F.L. Fimognari, S. Scarlata, M.E. Conte, R.A. Incalzi 2008 Mechanisms of atherothrombosis in chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 3 2008 89 96
10. J.R. Kizer, D.A. Zisman, N.P. Blumenthal Association between pulmonary fibrosis and coronary artery disease Arch Intern Med 164 2004 551 556
11. S.C. Smith Jr, E.J. Benjamin, R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association J Am Coll Cardiol 58 2011 2432 2446
12. S.C. Smith Jr, J. Allen, S.N. Blair AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 47 2006 2130 2139
13. Y. Gunes, M. Tuncer, U. Guntekin Reliability of symptoms suggestive of angina in patients with chronic obstructive pulmonary disease Arq Bras Cardiol 92 2009 334 335 364
14. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
15. J.A. Falk, S. Kadiev, G.J. Criner, S.M. Scharf, O.A. Minai, P. Diaz Cardiac disease in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 2008 543 548
16. J.R. Enriquez, S.V. Parikh, F. Selzer Increased adverse events after percutaneous coronary Iintervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute Dynamic Registry Chest 140 2011 604 610
17. C.L. Selvaraj, H.S. Gurm, R. Gupta, S.G. Ellis, D.L. Bhatt Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention Am J Cardiol 96 2005 756 759
18. J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010 J Heart Lung Transplant 29 2010 1104 1118
19. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
20. G. Raghu, Y.N. Mageto, D. Lockhart, R.A. Schmidt, D.E. Wood, J.D. Godwin The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study Chest 116 1999 1168 1174
21. R.M. Peckham, A.F. Shorr, D.L. Helman Jr Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis Respiration 71 2004 165 169
22. G. Izbicki, I. Ben-Dor, D. Shitrit The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med 103 2009 1346 1349
23. D.W. Leibowitz, A.L. Caputo, G.C. Shapiro Coronary angiography in smokers undergoing evaluation for lung transplantation: is routine use justified? J Heart Lung Transplant 13 1994 701 703
24. W.E. Boden, R.A. O'Rourke, K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
25. E.O. McFalls, H.B. Ward, T.E. Moritz Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
26. M.B. Rothberg, S.K. Sivalingam, J. Ashraf Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease Ann Intern Med 153 2010 307 313
27. A. Kulik, W.H. Shrank, R. Levin, N.K. Choudhry Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization Am J Cardiol 107 2011 1409 1414
28. R.A. Clough, B.J. Leavitt, J.R. Morton The effect of comorbid illness on mortality outcomes in cardiac surgery Arch Surg 137 2002 428 432
29. K. Nishiyama, T. Morimoto, Y. Furukawa Chronic obstructive pulmonary disease - an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease Int J Cardiol 143 2010 178 183
30. F. Roques, S.A. Nashef, P. Michel Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients Eur J Cardiothorac Surg 15 1999 816 822
31. G.E. Rosenthal, S.M. Vaughan, E.L. Hannan In-hospital mortality following coronary artery bypass graft surgery in Veterans Health Administration and private sector hospitals Med Care 41 2003 522 535
32. E. Erdmann Safety and tolerability of beta-blockers: prejudices & reality Indian Heart J 62 2010 132 135
33. M. Egred, S. Shaw, B. Mohammad, P. Waitt, E. Rodrigues Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease QJM 98 2005 493 497
34. E. Kotlyar, A.M. Keogh, P.S. Macdonald, R.H. Arnold, D.J. McCaffrey, A.R. Glanville Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma J Heart Lung Transplant 21 2002 1290 1295
35. M.R. Gold, G.W. Dec, D. Cocca-Spofford, B.T. Thompson Esmolol and ventilatory function in cardiac patients with COPD Chest 100 1991 1215 1218
36. A. Camsari, S. Arikan, C. Avan Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease Heart Vessels 18 2003 188 192
37. S. Salpeter, T. Ormiston, E. Salpeter Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 4 2005 CD003566
38. F.H. Rutten, N.P. Zuithoff, E. Hak, D.E. Grobbee, A.W. Hoes Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease Arch Intern Med 170 2010 880 887
39. M.R. Andrus, K.P. Holloway, D.B. Clark Use of beta-blockers in patients with COPD Ann Pharmacother 38 2004 142 145
40. S.S. Gottlieb, R.J. McCarter, R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
41. D.H. Au, C.L. Bryson, V.S. Fan Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease Am J Med 117 2004 925 931
42. R.M. Reed, A. Iacono, A. Defilippis, M. Eberlein, R.E. Girgis, S. Jones Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol J Heart Lung Transplant 30 6 2011 674 678
43. J.B. Orens, M. Estenne, S. Arcasoy International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 25 2006 745 755